On Apr. 17, 2006, the National Cancer Institute (NCI) announced initial results of the Study of Tamoxifen and…
On Jan. 17, 2006, researchers at the University of California, San Diego (UCSD) announced the development of a…
On May 6, 2005, the National Cancer Institute announced the Community Networks Program (CNP), a 5-year initiative to…
On May 3, 2005, the cellular pertussis vaccine combined with the adult formulation of tetanus and diphtheria (Tdap:…
On Apr. 27, 2005, results from two large National Cancer Institute sponsored randomized clinical trials showed that patients…
On Mar. 7, 2005, the Centers for Disease Control and Prevention (CDC) commissioned the Nebraska Biocontainment Unit (NBU) at…
On Sept. 22, 2004, the National Institutes of Health (NIH) opened the Mark O. Hatfield Clinical Research Center,…
On Sept. 13, 2004, the National Cancer Institute (NCI) announced the Alliance for Nanotechnology in Cancer, a 5-year…
On Jun. 26, 2004, the eighth and final report of the Immunization Safety Review Committee examines the hypothesis…
On Jun. 3, 2004, the National Cancer Institute’s (NCI) Annual Report to the Nation found cancer incidence and…
On Jul. 11, 2003, the U.S. Food and Drug Administration (FDA) published a final rule in the Federal…
On Jun. 24, 2003, results of the Prostate Cancer Prevention Trial (PCPT), testing the effectiveness of finasteride to…
On Jun. 17, 2003, the U.S. Food and Drug Administration (FDA) announced it had approved FluMist. This was…
On Dec. 24, 2002, the U.S. Food and Drug Administration’s (FDA) Office of Combination Products (OCP) was formed within…
On Dec. 1, 202, Sidney Kimmel, founder and chairman of Jones Apparel Group, donated $150 million for cancer…
On Sept. 19, 2002, a new approach to cancer treatment that replaced a patient’s immune system with cancer-fighting…
On Sept. 18, 2002, the National Cancer Institute (NCI) launched the National Lung Screening Trial to compare two…
On Jun. 19, 2002, National Cancer Institute (NCI) scientists used microarray technology to determine the patterns of genes…
On May 19, 2002, researchers from the National Cancer Institute reported that the molecularly targeted drug bevacizumab slowed…
On May 14, 2002, President George W. Bush signed the Hematologic Cancer Research Investment and Education Act of…
On Jun. 7, 2000, President Bill Clinton issued an Executive Memorandum that directed the Medicare program to revise…
In 2000, the Georgetown University Hospital became part of MedStar Health, a not-for-profit network of seven hospitals in…
On Aug. 27, 1999, Merck, West Point, Pennsylvania) received approval from the Food and Drug Administration (FDA) of…
On Jul. 11, 1999, Daiichi Sankyo and Eli Lilly announced the U.S. Food and Drug Administration (FDA) had…
On Mar. 17, 1999, the Hybrid Capture II human papillomavirus (HPV) DNA test was approved by the U.S….
In 1999, Trubion Pharmaceutical was founded in Seattle as a spin-off from the Pacific Northwest Diabetes Research Institute,…
On Jul. 20, 1998, the U.S. Food and Drug Administration (FDA) announced that the Modernization Act of 1997…
On Nov. 21, 1997, the U.S. Food and Drug Administration (FDA) Modernization Act (FDMA) was signed into law…
On Nov. 4, 1997, Vice President Al Gore and Senator Mark O. Hatfield attended groundbreaking ceremonies for the…
On Sept. 15, 1997, Wyeth-Ayerst Laboratories and Interneuron Pharmaceuticals, manufacturers of the popular off-label obesity combination therapy known…